The Herald Review

Correa pleads not guilty by phone from Graham County jail

Not guilty pleas were entered in a Cochise County courtroom on Monday for Paul Correa, who participated in his arraignment by ...
The Herald Review

Ignoring court orders sends Cochise County man to prison

A Cochise County man is now serving a five-year state prison term for aggravated harassment stemming from his decision to ...
San Diego Union-Tribune

Man accused in mother’s death in Vista ordered to stand trial

A man accused of causing fatal injuries to his 80-year-old mother in Vista was ordered Monday to stand trial on a charge of second-degree murder. Tad Christopher Johnson, 55, is accused of killing ...
Hosted on MSN

VistaGen’s PALISADE-3 trial fails primary endpoint in SAD

The latest update is out from VistaGen Therapeutics ( (VTGN)). On December 17, 2025, Vistagen Therapeutics reported that its PALISADE-3 Phase 3 clinical trial of intranasal fasedienol for the acute ...
Times of San Diego

Son to stand trial for 80-year-old mother’s fatal beating in Vista

A man accused of causing fatal injuries to his 80-year-old mother in Vista was ordered Monday to stand trial for second-degree murder. Tad Christopher Johnson, 55, is accused of killing Linda Johnson, ...
Hoodline

Vista Son Accused in Mom's Killing Ordered to Face Murder Trial

A Vista man accused of killing his 80-year-old mother will now face a felony trial, after a North County Superior Court judge on Monday ordered him held to answer following a preliminary hearing. The ...
ABC News

Sean 'Diddy' Combs trial updates: Bail denied due to 'propensity for violence'

Combs was convicted of two counts of transportation to engage in prostitution. This story may contain accounts and descriptions of actual or alleged events that some readers may find disturbing. Read ...
Investing

Vistagen stock plummets after failed anxiety treatment trial

Investing.com -- Vistagen (NASDAQ:VTGN) stock plunged 78.8% Wednesday after the company announced its Phase 3 study of fasedienol for social anxiety disorder failed to meet its primary endpoint. The ...
Investing

VistaGen stock rating downgraded by William Blair after trial miss

Investing.com - VistaGen Therapeutics (NASDAQ:VTGN) stock rating was downgraded from Outperform to Market Perform by William Blair following disappointing Phase III clinical trial results. The stock, ...
Seeking Alpha

Vistagen fails in late-stage trial for social anxiety disorder therapy

Vistagen (VTGN) on Wednesday announced that a Phase 3 trial for fasedienol, an experimental therapy for social anxiety disorder, did not achieve its primary endpoint. Shares of the California-based ...
BioSpace

CREATE Medicines Doses First Patient in Frontline HCC Trial Evaluating MT-303, an In Vivo CAR Therapy, in Combination with Standard-of-Care Immunotherapy

Frontline setting accelerates potential for deep, durable responses in the treatment of liver cancers Study builds on clinical validation from one of the largest datasets in the in vivo CAR field ...